Migraine in Pregnancy

Česká verze

Authors: V. Peterová ^1,2; M. Kron ¹; A. Vojtěchová ¹; J. Hovorka ³
Authors place of work: MR oddělení, Radiodiagnostická klinika 1. LF UK a VFN, Praha ¹; Neurologická ambulance, Antala Staška 80, Praha 4 ²; Neurologické oddělení, Neuropsychiatrické a epileptologické centrum, Nemocnice Na Františku s poliklinikou, Praha ³
Published in the journal: Cesk Slov Neurol N 2008; 71/104(3): 336-341
Category: Krátké sdělení

Summary

The authors analyze migraine types, diagnostics and examinations with different treatment possibilities in pregnant migraineurs. The study is based on the team's own medical outpatients ward practice from 1990 to 2006, involving a total of 288 investigated migraineurs, 26 of whom were treated during pregnancy. The aim of the work was to ascertain the occurrence, type and characteristics of migrainous attacks during the pregnancy migraineurs including those in whom the first attack took place during pregnancy. All patients were investigated on a regular basis by neurologists, by EEG and 1.5T magnetic resonance. Migraine without aura in our patients' group affected 88.46 % of persons, while 7.68% of persons suffered from migraine with aura, retinal migraine was present in 1 person. A visual aura was most frequent in cases of migraine with aura.

Results:
newly occurring attacks always appeared in 1st trimester. Frequency, intensity and duration of attacks improved significantly already in 1st trimester in 13% of migraineurs. In 7 % of persons, attacks did not occur during pregnancy. Only patients whose migraines were associated with menstruation experienced a reduction or the total disappearance of attacks. 53 % of pregant migraineurs experienced improvement in the 2nd trimester, 28 % of the patients experienced further improvement in the 3rd trimester. Frequency of attacks increased after delivery in the case 45% of migraineurs.

Conclusion:
patients whose migraines were associated with menstruation or menarche experienced significant reductions in attacks during pregnancy. Maximum migraine frequency in pregnant migraineurs appears in 1st trimester. Pregnancy has favourable influence on migraine predominantly in 2nd and 3rd trimesters (in up to 81 % persons). Treatment is aimed at the elimination of migraine trigger factors and non-pharmacological treatment. Pharmacological treatment of pregnant migraineurs is possible and is described in this article.

Key words:
migraine – pregnancy

Zdroje

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalgia 1988; 8(Suppl 7): 1–96.

2. Peterová V, Obenberger J, Seidl Z. Léčba bolestí hlavy ovlivněním úzkosti. Prakt Lék 2000; 10(80): 579–581.

3. Peterová V, Dostál C, Olejárová M, Seidl Z, Daneš J. MR nálezy u nemocných s lupusovou cefaleou. Čs Radiol 2003; 57(6): 325–329.

4. Waberžinek G, Keller O, Marková J. Bolesti hlavy - současná klasifikace, diagnóza a léčba. Cesk Slov Neurol N 1999; 62/95(5): tematická příloha: 1–16.

5. Peterová V, Seidl Z, Viták T, Daneš J. Migrenózní aura. Cesk Slov Neurol N 2003; 66/99(4): 297–303.

6. Stewart WF, Schechter A, Rasmussen BK. Migraine prevalence: a review of population - based studies. Neurology 1994; 44(6 Suppl 4): S17–S23.

7. Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options? Drug Saf 1998;19(5): 383–388.

8. Chancellor AM, Wroe SJ, Cull RE. Migraine occuring for the first time in pregnancy. Headache 1990; 30(4): 224–227.

9. Silberstein SD. Headaches and women: treatment of the pregnant and lactating migraineur. Headache 1993; 33(10): 533–540.

10. Aubé M. Migraine in pregnancy. Neurology 1999; 53(4 Suppl 1): S26–S28.

11. Ratinahirana H, Darbois Y, Bousser MG. Migraine and pregnancy: a prospective study in 703 women after delivery. Neurology 1990; 40(Suppl 1): 437.

12. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995;15(2): 140–144.

13. Lance JW, Anthony M. Some clinical aspects of migraine: A prospective survey of 500 patients. Arch Neurol 1966; 15(4): 356–361.

14. Scharff L, Marcus DA, Turk DC. Headache during pregnancy in the postpartum: a prospective study. Headache 1997; 37(4): 203–210.

15. Somerville BW. A study of migraine in pregnancy. Neurology 1972; 22(8): 824–828.

16. Somerville BW. The role of oestradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22(4): 355–365.

17. Fox AW, Diamond ML, Spierings EL. Migraine during pregnancy: options for therapy. CNS Drugs 2005; 19(6): 465–481.

18. Lance JW. Migraine treatment. Migraine: clinical aspects. In: Lance J, Goadsby PJ (eds). Mechanism and management of headache. Oxford: Butterworth - Heinemann Ltd. 1993: 68–90, 116–143.

19. Silberstein SD. Headaches in pregnancy. Neurol Clin 2004; 22(4): 727–756.

20. Peterová V, Seidl Z, Obenberger J. Ketoprofen v léčbě bolestí hlavy. Prakt Lék 2000; 80(1): 35–36.

21. Peterová V, Seidl Z. Praktické zkušenosti se zolmitriptanem v léčba akutního záchvatu u migreniků bez aury. Prakt Lék 2003; 83(12): 704–708.

22. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003; 23(3): 197–205.

23. Allais G, Bosio A, Mana O, Airola G, Ciochetto D, Terzi MG et al. Migraine during pregnancy and lactation: treatment of the acute attack and non-pharmacological prophylactic strategies. Minerva Med 2003; 94 (4 Suppl 1): 27–38.

24. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalgia 1988; 8(Suppl 7): 1–96.

25. Opavský J, Keller O, Kotas R, Mastík J, Marková J, Rejda J et al. Česká verze revidované Mezinárodní klasifikace bolestí hlavy (ICHD-II) navržené a předložené Mezinárodní společností pro bolesti hlavy. Cesk Slov Neurol N 2005; 68/101(2): 133–138.

26. Salfield SA, Wardley BL, Houlsby WT, Turner SL, Spalton AP, Herber SM et al. Controlled study of exclusion of dietary vasoactive amines in migraine. Arch Dis Child 1987; 62(5): 458–460.

27. Scharff L, Marcus DA. The association between chocolate and migraine: A review. Headache Q 1999;10: 199–205.

28. Shulman KI, Walker SE. Refining the MAOI diet. Tyramine content of pizzas and soy products. J Clin Psychiatry 1999; 60: 191–193.